The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with <i>EGFR</i> Mutations
This retrospective study was undertaken to investigate the impact of initial gefitinib or erlotinib (EGFR tyrosine kinase inhibitor, EGFR-TKI) versus chemotherapy on the risk of central nervous system (CNS) progression in advanced non-small cell lung cancer (NSCLC) with EGFR mutations.Patients with...
-д хадгалсан:
Үндсэн зохиолчид: | , , , , , , , , , |
---|---|
Формат: | Artigo |
Хэл сонгох: | англи |
Хэвлэсэн: |
2012
|
Онлайн хандалт: | https://doi.org/10.1158/1078-0432.ccr-12-0357 |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|